Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 25, 2004
Platelet function unaffected by ozonated autohaemotherapy in chronically haemodialysed patientsLeszek Tylicki, Slawomir Lizakowski, Bogdan Biedunkiewicz, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|June 29, 2010
The effect of N-acetylcysteine on blood pressure and markers of cardiovascular risk in non-diabetic patients with chronic kidney disease: a placebo-controlled, randomized, cross-over studyMarcin Renke, Leszek Tylicki, Przemysław Rutkowski, et al.
American Journal of Hypertension|November 11, 2005
Methylenetetrahydrofolate reductase gene polymorphisms in essential hypertension relation: with the development of hypertensive end-stage renal diseaseLeszek Tylicki, Manuela Födinger, Heidemarie Puttinger, et al.
Transplantation Proceedings|August 12, 2022
Safety and Tolerability of mRNA COVID-19 Vaccines in Kidney Transplant RecipientsZuzanna Ślizień, Marta Muchlado, Alicja Kubanek, et al.
Artificial Organs|February 14, 2004
Ozonated autohemotherapy in patients on maintenance hemodialysis: influence on lipid profile and endotheliumLeszek Tylicki, Bogdan Biedunkiewicz, Tomasz Nieweglowski, et al.
Polish Archives of Internal Medicine|August 5, 2021
Humoral response to SARS-CoV-2 vaccination promises to improve the catastrophic prognosis of hemodialysis patients as a result of COVID-19: the COViNEPH ProjectLeszek Tylicki, Bogdan Biedunkiewicz, Małgorzata Dąbrowska, et al.
Acta Biochimica Polonica|November 17, 2010
Atorvastatin improves tubular status in non-diabetic patients with chronic kidney disease - placebo controlled, randomized, cross-over studyMarcin Renke, Leszek Tylicki, Przemysław Rutkowski, et al.
Transplantation Proceedings|May 2, 2022
Changes in Kidney Graft Function in COVID-19 ConvalescentsAgnieszka Malinowska, Zbigniew Heleniak, Marta Muchlado, et al.
American Journal of Hypertension|February 24, 2012
Aliskiren and perindopril reduce the levels of transforming growth factor-β in patients with non-diabetic kidney diseaseSławomir Lizakowski, Leszek Tylicki, Marcin Renke, et al.
Journal of Clinical Medicine|October 13, 2021
Persistent Post-COVID-19 Syndrome in Hemodialyzed Patients-A Longitudinal Cohort Study from the North of PolandAleksander Och, Piotr Tylicki, Karolina Polewska, et al.
Pageof 8